These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 554711)

  • 1. Comparative evaluation of BVDU ((E)-5-(2-bromovinyl)-2'-deoxyuridine) in the treatment of experimental herpes simplex keratitis in rabbits.
    Maudgal PC; De Clercq E; Descamps J; Missotten L
    Bull Soc Belge Ophtalmol; 1979; 186():109-18. PubMed ID: 554711
    [No Abstract]   [Full Text] [Related]  

  • 2. (E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis.
    Maudgal PC; De Clercq E; Descamps J; Missotten L; De Somer P; Busson R; Vanderhaeghe H; Verhelst G; Walker RT; Jones AS
    Antimicrob Agents Chemother; 1980 Jan; 17(1):8-12. PubMed ID: 7352751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ac2IDU, BVDU, and thymine arabinoside therapy in experimental herpes keratitis.
    Hettinger ME; Pavan-Langston D; Park NH; Albert DM; De Clercq E; Lin TS
    Arch Ophthalmol; 1981 Sep; 99(9):1618-21. PubMed ID: 7283815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of bromovinyldeoxyuridine-related compounds in the treatment of experimental herpes simplex keratitis.
    Maudgal PC; De Clercq E
    Arch Ophthalmol; 1985 Sep; 103(9):1393-7. PubMed ID: 4038133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of idoxuridine analogs into corneal herpes simplex virus.
    Hanna C
    Ann Ophthalmol; 1972 Nov; 4(11):991-6. PubMed ID: 4265776
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of bromovinyldeoxyuridine in the treatment of herpes simplex virus and varicella-zoster virus eye infections.
    Maudgal PC; De Clercq E; Missotten L
    Antiviral Res; 1984 Oct; 4(5):281-91. PubMed ID: 6335020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapeutic activity of bonafton in experimental herpetic keratitis in rabbits].
    Bogdanova NS; Nikolaeva IS; Pershin GN
    Farmakol Toksikol; 1975; 38(6):728-32. PubMed ID: 1227924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine in the topical treatment of herpes simplex keratitis.
    Maudgal PC; Missotten L; De Clercq E; Descamps J; De Meuter E
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1981; 216(4):261-8. PubMed ID: 7020469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil (BrVaraU, VaraU) in the treatment of experimental herpes simplex virus type 1 keratitis in rabbits: comparison with (E)-5-(2-bromovinyl)-2'-deoxyuridine (BrVUdR).
    Töpke H; Gräf M; Wutzler P; Herrmann G; Reefschläger J
    Antiviral Res; 1988 Jul; 9(4):273-80. PubMed ID: 3202622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experiences with trifluorothymidine in herpes simplex keratitis.
    Bigar F
    Adv Ophthalmol; 1979; 38():110-5. PubMed ID: 118650
    [No Abstract]   [Full Text] [Related]  

  • 11. [Superficial herpes simplex keratitis. Double-blind comparative trial of acyclovir and idoxuridine (author's transl)].
    Colin J; Tournoux A; Chastel C; Renard G
    Nouv Presse Med; 1981 Oct; 10(36):2969-70, 2975. PubMed ID: 7027178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular penetration and efficacy of chloroethyldeoxyuridine against herpetic keratouveitis.
    Maudgal PC; De Clercq E; Bernaerts R; Dieltiens M; Breemersch M; Van Eeckhoutte L
    Invest Ophthalmol Vis Sci; 1986 Oct; 27(10):1453-8. PubMed ID: 3759363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine in the therapy of thymidine kinase-positive and -deficient herpes simplex virus experimental keratitis.
    Maudgal PC; De Clercq E
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1816-20. PubMed ID: 1851733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissemination of corneal herpes simplex.
    Maloney ED; Kaufman HE
    Invest Ophthalmol; 1965 Oct; 4(5):872-5. PubMed ID: 5319142
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of (S)-HPMPA against thymidine kinase-deficient herpes simplex virus-keratitis.
    Maudgal PC; De Clercq E; Huyghe P
    Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):243-8. PubMed ID: 8591903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular penetration of (125I)IVDU, a radiolabeled analogue of bromovinyldeoxyuridine.
    Maudgal PC; Verbruggen AM; De Clercq E; Busson R; Bernaerts R; de Roo M; Ameye C; Missotten L
    Invest Ophthalmol Vis Sci; 1985 Jan; 26(1):45-9. PubMed ID: 3967955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idoxuridine ocular insert therapy. Use in treatment of experimental Herpes simplex keratitis.
    Pavan-Langston D; Langston RH; Geary PA
    Arch Ophthalmol; 1975 Dec; 93(12):1349-51. PubMed ID: 173270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil against acute herpes simplex virus keratitis and the establishment of latency: comparison with acyclovir and bromovinyldeoxyuridine.
    Rajcáni J; Reefschläger J
    Acta Virol; 1987 Aug; 31(4):329-39. PubMed ID: 2892382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acyclovir and acyclovir in combination with interferon in the treatment of ophthalmic herpes].
    Maĭchuk IuF; Kazachenko MA
    Oftalmol Zh; 1988; (7):402-5. PubMed ID: 3237367
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental stroma herpes simplex keratitis. Influence of treatment with topical bromovinyldeoxyuridine and trifluridine.
    Maudgal PC; De Clercq E; Descamps J; Missotten L; Wijnhoven J
    Arch Ophthalmol; 1982 Apr; 100(4):653-6. PubMed ID: 6803747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.